Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02205047 |
| Title | Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma (INNOVATION) |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | European Organisation for Research and Treatment of Cancer - EORTC |
| Indications | |
| Therapies |
Cisplatin + Fluorouracil + Pertuzumab + Trastuzumab Cisplatin + Fluorouracil + Trastuzumab |
| Age Groups: | senior | adult |
| Covered Countries | ITA | FRA | ESP | DEU | BEL |